Maria Eberg, MSc

Senior Consultant
IQVIA, Canada

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1252 - A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET